D72.1 Eosinophilia

Name of the Condition

• Common Name: Eosinophilia
• Medical Terms: Eosinophilia

Summary

Eosinophilia (D72.1) is a condition defined by an elevated number of eosinophils, a type of white blood cell, in the bloodstream or tissues. This code is used when eosinophilia is present but not associated with a specific underlying condition or syndrome. The elevated eosinophil count may be detected incidentally or as part of evaluating symptoms related to allergic, infectious, or inflammatory processes.

Causes

Eosinophilia can result from a variety of triggers, including allergic reactions (e.g., asthma, atopic dermatitis), parasitic infections, autoimmune diseases, certain medications, or malignancies. In some cases, the cause remains unidentified, and the condition is documented as isolated eosinophilia.

Risk Factors

• History of allergies or asthma
• Exposure to environmental allergens or parasites
• Use of medications known to induce eosinophilia (e.g., certain antibiotics, anticonvulsants)
• Underlying autoimmune or inflammatory conditions
• Recent travel to regions with endemic parasitic infections

Symptoms

• Often asymptomatic and identified during routine blood tests
• If symptomatic, may include fatigue, cough, rash, or abdominal pain, depending on the underlying trigger
• Severe cases can involve organ-specific symptoms (e.g., respiratory distress, skin lesions)

Diagnosis

Diagnosis is confirmed through a complete blood count (CBC) showing elevated eosinophil levels. Further evaluation may include allergy testing, imaging, or tissue biopsies to rule out underlying causes. The D72.1 code is applied when no specific etiology is identified or documented.

Treatment Options

Treatment focuses on addressing the underlying cause if identified (e.g., discontinuing a triggering medication, treating an infection). For idiopathic cases, management may involve monitoring and symptomatic care. Corticosteroids or other immunosuppressants may be used in severe or persistent cases.

Prognosis and Follow-Up

Prognosis depends on the underlying cause. Isolated eosinophilia with no identifiable trigger often has a favorable outcome with monitoring. Regular follow-up is recommended to assess eosinophil levels and detect any developing complications.

Complications

• Organ damage (e.g., heart, lungs, or gastrointestinal tract) in severe or prolonged cases
• Chronic inflammation or fibrosis
• Increased risk of secondary infections

Lifestyle & Prevention

• Avoid known allergens or triggers
• Practice good hygiene to reduce parasitic infection risk
• Follow medication guidelines and report adverse reactions promptly
• Maintain regular health check-ups for early detection

When to Seek Professional Help

Seek medical attention if symptoms worsen, new symptoms develop, or if eosinophil levels remain elevated during follow-up. Prompt evaluation is necessary for severe symptoms (e.g., difficulty breathing, chest pain) or signs of organ involvement.

Tips for Medical Coders

Use D72.1 for cases of eosinophilia where the underlying cause is not specified or documented. Ensure documentation supports the absence of associated conditions (e.g., HES, DRESS) to avoid miscoding. Verify that eosinophil levels are elevated and that no other codes apply before assigning this code.